BMH BRÄUTIGAM advises Balderton on € 16 million financing round of Clue
BMH BRÄUTIGAM has advised Balderton Capital in the financing round of the Berlin-based femtech company Clue in the amount of €16 million. In addition to lead investor Balderton, Future Positive Capital also participated in the financing round as a new investor.
Clue is a leading femtech company that aims to change the way people around the world deal with issues such as menstruation, contraception and fertility with its cycle and fertility app by combining science and technology. With Clue Birth Control, the company has developed a technology-enabled, easy-to-use, side-effect-free, hormone-free, and evidence-based contraceptive method that will serve the global need for easily accessible and, first and foremost, reliable contraception in the future beyond the U.S. market. The company will use the fresh capital to expand the Berlin team and invest in new product development. Background: BMH BRÄUTIGAM regularly advises on financing rounds on both the investor and company sides. Balderton was represented by BMH BRÄUTIGAM after a recommendation from its network. Team BMH BRÄUTIGAM: Dr. Alexander Wulff, Till Wansleben, Maximilian Frink (all Venture Capital)